PRECIGEN, INC. Interest Expense
PRECIGEN, INC. (PGEN) reported Interest Expense of $4.47 million for the 3-month period ending 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2019-11-12
- PRECIGEN, INC. interest expense for the quarter ending 2019-09-30 was $4.47M, a 11.80% increase year-over-year.
- PRECIGEN, INC. interest expense for the quarter ending 2019-06-30 was $4.36M, a 2969.01% increase year-over-year.
- PRECIGEN, INC. interest expense for the quarter ending 2019-03-31 was $4.31M, a 4254.55% increase year-over-year.
- PRECIGEN, INC. interest expense for the quarter ending 2018-12-31 was $4.29M, a 3696.46% increase year-over-year.
- PRECIGEN, INC. interest expense for fiscal 2018 was $8.53M, a 1296.07% increase from fiscal 2017.
- PRECIGEN, INC. interest expense for fiscal 2017 was $611.00K, a 29.04% decline from fiscal 2016.
- PRECIGEN, INC. interest expense for fiscal 2016 was $861.00K, a 30.79% decline from fiscal 2015.
- PRECIGEN, INC. interest expense for fiscal 2015 was $1.24M, a 86.79% increase from fiscal 2014.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2019-09-30 | $4.47M 10-Q · filed 2019-11-12 | $8.83M derived: sum of 2 quarters · filed 2019-11-12 | $13.14M 10-Q · filed 2019-11-12 | $17.43M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-06-30 | $4.36M 10-Q · filed 2019-08-09 | $8.67M 10-Q · filed 2019-08-09 | $12.96M derived: sum of 3 quarters · filed 2019-08-09 | $16.96M derived: sum of 4 quarters · filed 2019-11-12 |
| 2019-03-31 | $4.31M 10-Q · filed 2019-05-09 | $8.60M derived: sum of 2 quarters · filed 2019-05-09 | $12.60M derived: sum of 3 quarters · filed 2019-11-12 | $12.74M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-12-31 | $4.29M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $8.29M derived: sum of 2 quarters · filed 2019-11-12 | $8.43M derived: sum of 3 quarters · filed 2019-11-12 | $8.53M 10-K · filed 2019-03-01 |
| 2018-09-30 | $4.00M 10-Q · filed 2019-11-12 | $4.14M derived: sum of 2 quarters · filed 2019-11-12 | $4.24M 10-Q · filed 2019-11-12 | $4.35M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $142.00K 10-Q · filed 2019-08-09 | $241.00K 10-Q · filed 2019-08-09 | $354.00K derived: sum of 3 quarters · filed 2019-08-09 | $492.00K derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $99.00K 10-Q · filed 2019-05-09 | $212.00K derived: sum of 2 quarters · filed 2019-05-09 | $350.00K derived: sum of 3 quarters · filed 2019-05-09 | $531.00K derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | $113.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $251.00K derived: sum of 2 quarters · filed 2019-03-01 | $432.00K derived: sum of 3 quarters · filed 2019-03-01 | $611.00K 10-K · filed 2019-03-01 |
| 2017-09-30 | $138.00K 10-Q · filed 2018-11-08 | $319.00K derived: sum of 2 quarters · filed 2018-11-08 | $498.00K 10-Q · filed 2018-11-08 | $600.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $181.00K 10-Q · filed 2018-08-13 | $360.00K 10-Q · filed 2018-08-13 | $462.00K derived: sum of 3 quarters · filed 2019-03-01 | $689.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $179.00K 10-Q/A · filed 2018-08-13 | $281.00K derived: sum of 2 quarters · filed 2019-03-01 | $508.00K derived: sum of 3 quarters · filed 2019-03-01 | $775.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $329.00K derived: sum of 2 quarters · filed 2019-03-01 | $596.00K derived: sum of 3 quarters · filed 2019-03-01 | $861.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $227.00K 10-Q · filed 2017-11-09 | $494.00K derived: sum of 2 quarters · filed 2017-11-09 | $759.00K 10-Q · filed 2017-11-09 | $991.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $267.00K 10-Q · filed 2017-08-09 | $532.00K 10-Q · filed 2017-08-09 | $764.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.07M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $265.00K 10-Q · filed 2017-05-10 | $497.00K derived: sum of 2 quarters · filed 2018-03-01 | $807.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.17M derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $232.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $542.00K derived: sum of 2 quarters · filed 2018-03-01 | $901.00K derived: sum of 3 quarters · filed 2018-03-01 | $1.24M 10-K · filed 2018-03-01 |
| 2015-09-30 | $310.00K 10-Q · filed 2016-11-09 | $669.00K derived: sum of 2 quarters · filed 2016-11-09 | $1.01M 10-Q · filed 2016-11-09 | $1.37M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $359.00K 10-Q · filed 2016-08-09 | $702.00K 10-Q · filed 2016-08-09 | $1.06M derived: sum of 3 quarters · filed 2017-03-01 | $1.29M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | $343.00K 10-Q · filed 2016-05-10 | $700.00K derived: sum of 2 quarters · filed 2017-03-01 | $930.00K derived: sum of 3 quarters · filed 2017-03-01 | $970.00K derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $587.00K derived: sum of 2 quarters · filed 2017-03-01 | $627.00K derived: sum of 3 quarters · filed 2017-03-01 | $666.00K 10-K · filed 2017-03-01 |
| 2014-09-30 | $230.00K 10-Q · filed 2015-11-09 | $270.00K derived: sum of 2 quarters · filed 2015-11-09 | $309.00K 10-Q · filed 2015-11-09 | $419.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $40.00K 10-Q · filed 2015-08-10 | $79.00K 10-Q · filed 2015-08-10 | $189.00K derived: sum of 3 quarters · filed 2016-02-29 | $195.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $39.00K 10-Q · filed 2015-05-11 | $149.00K derived: sum of 2 quarters · filed 2016-02-29 | $155.00K derived: sum of 3 quarters · filed 2016-02-29 | $166.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $110.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $116.00K derived: sum of 2 quarters · filed 2016-02-29 | $127.00K derived: sum of 3 quarters · filed 2016-02-29 | $141.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $6.00K 10-Q · filed 2014-11-13 | $17.00K derived: sum of 2 quarters · filed 2014-08-14 | $31.00K 10-Q · filed 2014-11-13 | $46.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | $11.00K 10-Q · filed 2014-08-14 | $25.00K 10-Q · filed 2014-08-14 | $40.00K derived: sum of 3 quarters · filed 2015-03-02 | $57.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $14.00K 10-Q · filed 2014-05-09 | $29.00K derived: sum of 2 quarters · filed 2015-03-02 | $46.00K derived: sum of 3 quarters · filed 2015-03-02 | $64.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2012-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $32.00K derived: sum of 2 quarters · filed 2015-03-02 | $50.00K derived: sum of 3 quarters · filed 2015-03-02 | $57.00K 10-K · filed 2015-03-02 |
| 2012-09-30 | $17.00K 10-Q · filed 2013-11-07 | $35.00K derived: sum of 2 quarters · filed 2013-11-07 | $42.00K 10-Q · filed 2013-11-07 | |
| 2012-06-30 | $18.00K 10-Q/A · filed 2013-10-21 | $25.00K 10-Q/A · filed 2013-10-21 | ||
| 2011-12-31 | $183.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |